<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The hallmark of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is enhanced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in myeloid, erythroid, and megakaryocytic cells in the bone marrow leading to ineffective hematopoiesis </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies suggested that immunological and microenvironmental factors play a role in the pathophysiology of this disease </plain></SENT>
<SENT sid="2" pm="."><plain>We report a significant increase in <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in bone marrow B lymphocytes in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> as compared to that found in <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> and healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, we demonstrate that patients with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>) had <z:mpath ids='MPATH_3'>apoptosis</z:mpath> levels in lymphocytes similar to those seen in other subtypes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Our findings suggest that the alterations in B lymphocytes in the form of <z:mp ids='MP_0006042'>increased apoptosis</z:mp> can be seen in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and support the concept that immune modulation plays a role in the pathophysiology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>